Vertex Pharmaceuticals
|
Vertex Pharmaceuticals Incorporated (Vertex) is a biotechnology company in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Telaprevir, lead drug candidate, is an oral hepatitis C protease inhibitor and one of the advanced of a new class of antiviral treatments in clinical development that target hepatitis C virus (HCV), infection. Vertex’s other drug candidates are VX-770 and VX-809, two drug candidates targeting cystic fibrosis, or CF; VX-500 and VX-813, two second-generation HCV protease inhibitors; and VX-509, a janus kinase 3, or JAK3, inhibitor that targets immune-mediated inflammatory diseases, or IMID. The Company...
More from Zoominfo » |
|
|
